These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 34146727)
1. Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient. Dumortier J Clin Res Hepatol Gastroenterol; 2022 Jan; 46(1):101743. PubMed ID: 34146727 [No Abstract] [Full Text] [Related]
2. Immune Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Liver Transplant Recipients. Odriozola A; Lamadrid-Perojo P; Cuadrado A; San Segundo D; Del Barrio M; Fortea JI; Puente A; Amigo L; Fernández-Santiago R; Castillo F; Achalandabaso M; Andrés Echeverri J; Rodríguez-Sanjuan JC; López-Hoyos M; Crespo J; Fábrega E Transplantation; 2022 Jul; 106(7):e341-e342. PubMed ID: 35323163 [No Abstract] [Full Text] [Related]
3. Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients. Haller MC; Kaiser RA; Langthaler S; Brandstetter C; Apfalter P; Kerschner H; Cejka D Transpl Int; 2021; 35():10026. PubMed ID: 35185359 [No Abstract] [Full Text] [Related]
5. New-onset autoimmune hepatitis following mRNA COVID-19 vaccination in a 36-year-old woman with primary sclerosing cholangitis - should we be more vigilant? Zhou T; Fronhoffs F; Dold L; Strassburg CP; Weismüller TJ J Hepatol; 2022 Jan; 76(1):218-220. PubMed ID: 34450237 [No Abstract] [Full Text] [Related]
6. A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients. Benotmane I; Bruel T; Planas D; Fafi-Kremer S; Schwartz O; Caillard S Kidney Int; 2022 May; 101(5):1073-1076. PubMed ID: 35231463 [No Abstract] [Full Text] [Related]
7. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech). Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063 [TBL] [Abstract][Full Text] [Related]
8. Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients - the Vienna Cohort. Beilhack G; Monteforte R; Frommlet F; Gaggl M; Strassl R; Vychytil A Front Immunol; 2021; 12():780594. PubMed ID: 34925359 [TBL] [Abstract][Full Text] [Related]
9. Clinical Factors Associated With Lack of Serological Response to SARS-CoV-2 Messenger RNA Vaccine in Liver Transplantation Recipients. Cholankeril G; Al-Hillan A; Tarlow B; Abrams D; Jacobs JS; Flores NP; Rana A; Kanwal F; Goss JA Liver Transpl; 2022 Jan; 28(1):123-126. PubMed ID: 34724328 [No Abstract] [Full Text] [Related]
10. Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine. Wang M; Wen W; Zhou M; Wang C; Feng ZH Am J Cardiol; 2022 Mar; 167():155-157. PubMed ID: 35063268 [No Abstract] [Full Text] [Related]
12. COVID-19 in a kidney transplant recipient after mRNA-based SARS-CoV-2 vaccination. Tsalouchos A; Rossolini GM; Maggi L; Mazzoni A; Annunziato F; Dattolo PC Transpl Infect Dis; 2021 Aug; 23(4):e13649. PubMed ID: 34032340 [No Abstract] [Full Text] [Related]
13. Acceptance of SARS-CoV-2 vaccines by liver transplant recipients and candidates. Reuken PA; Albers S; Rauchfuss F; Strnad P; Settmacher U; Trautwein C; Stallmach A; Bruns T Z Gastroenterol; 2021 Dec; 59(12):1288-1296. PubMed ID: 34670294 [TBL] [Abstract][Full Text] [Related]
14. Young Male With Myocarditis Following mRNA-1273 Vaccination Against Coronavirus Disease-2019 (COVID-19). Kaneta K; Yokoi K; Jojima K; Kotooka N; Node K Circ J; 2022 Mar; 86(4):721. PubMed ID: 34744118 [No Abstract] [Full Text] [Related]
15. Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipients. Toniutto P; Aghemo A; Grossi P; Burra P; Dig Liver Dis; 2021 Oct; 53(10):1232-1234. PubMed ID: 34393073 [No Abstract] [Full Text] [Related]
16. Sars-Cov-2 vaccination in liver transplant recipients: The 'holy grail' in a hostile environment. Burra P; Russo FP Liver Int; 2022 Jun; 42(6):1225-1228. PubMed ID: 35678039 [No Abstract] [Full Text] [Related]
17. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases. Thuluvath PJ; Robarts P; Chauhan M J Hepatol; 2021 Dec; 75(6):1434-1439. PubMed ID: 34454993 [TBL] [Abstract][Full Text] [Related]
18. Myocarditis after vaccination against covid-19. Gellad WF BMJ; 2021 Dec; 375():n3090. PubMed ID: 34916217 [No Abstract] [Full Text] [Related]
19. Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients. Benotmane I; Gautier-Vargas G; Cognard N; Olagne J; Heibel F; Braun-Parvez L; Martzloff J; Perrin P; Moulin B; Fafi-Kremer S; Caillard S Kidney Int; 2021 Jun; 99(6):1487-1489. PubMed ID: 33775674 [No Abstract] [Full Text] [Related]
20. Adjustment of Immunosuppressants to Facilitate Anti-COVID-19 Antibody Production after mRNA Vaccination in Liver Transplant Recipients. Lee WC; Hung HC; Lee JC; Huang CG; Huang PW; Gu PW; Wang YC; Cheng CH; Wu TH; Lee CF; Wu TJ; Chou HS; Chan KM Viruses; 2023 Mar; 15(3):. PubMed ID: 36992386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]